Company Overview
Ascent Industries Co. engages in the development, production, and distribution of specialty chemical solutions, offering a range of products including surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates in both petroleum-based and bio-based formulations. The company operates within the Basic Materials sector and specifically within the Chemicals industry, positioning it as a provider of essential industrial inputs used across various manufacturing processes. Ascent Industries Co. maintains a market capitalization of $121.97M and generates annual revenue of $74.94M with an operational workforce of 197 employees. These valuation and revenue figures indicate that the company operates as a small-cap entity within the broader chemical landscape, suggesting a focused operational scope rather than a diversified conglomerate structure. The modest market cap relative to its revenue stream implies a valuation that is sensitive to specific niche market dynamics and production efficiency rather than broad consumer demand fluctuations.
Financial Health
The company reported revenue of $74.94M over the trailing twelve months, while posting a net income of $-5,584,000 and an EBITDA of $-2,766,000. The significant gap between positive revenue and negative net income reveals a cost structure where operating expenses, likely driven by raw material costs or manufacturing overhead, exceed gross profits before accounting for interest and taxes. Despite the reported net loss, the company generated free cash flow of $32.11M, which indicates a strong ability to convert earnings into cash and suggests significant financial flexibility to fund operations or reduce leverage without relying on external financing. The gross margin stands at 23.0%, indicating that the company retains a substantial portion of revenue after direct production costs, though the operating margin of -16.8% and profit margin of 1.2% demonstrate that fixed costs are currently consuming a large share of those gross profits. On the balance sheet, the company holds $57.61M in cash against $13.78M in debt, resulting in a debt-to-equity ratio of 15.84, which presents a complex picture of high leverage metrics offset by substantial cash reserves that provide a buffer against interest obligations. The current ratio of 6.72 indicates robust short-term liquidity, suggesting the company possesses more than six times the current assets necessary to cover its current liabilities. Furthermore, the return on equity is -6.2% and the return on assets is -3.4%, metrics that reveal management is currently generating negative returns on the capital invested, reflecting the impact of the reported net losses on the overall efficiency of asset utilization and shareholder equity.
Valuation Assessment
The trailing twelve-month P/E ratio is listed as N/A due to the negative net income, while the forward P/E is 16.10. The absence of a trailing P/E combined with a forward P/E of 16.10 implies that the market is pricing in a recovery or improvement in earnings trajectory expected in the coming period, as current profitability does not support a traditional valuation multiple. The price-to-book ratio is 1.39, indicating that the market values the company at a premium of 39% over its net asset book value, which can suggest investor confidence in intangible assets or future growth potential despite current earnings losses. Alternative valuation metrics such as the price-to-sales ratio of 1.63 and an EV/EBITDA of -28.25 provide further context; the negative EV/EBITDA confirms the company is currently unprofitable on an earnings basis, while the price-to-sales ratio suggests the company is trading at a valuation that is somewhat elevated relative to its sales volume. The 52-week high is $17.92 and the 52-week low is $11.46, meaning the current trading price sits within this range, specifically reflecting a valuation that is neither at the peak nor at the bottom of the recent volatility observed over the last year. The beta value is 0.44, which signifies that the stock price exhibits low volatility relative to the broader market, moving less than half as much as the overall index during periods of market fluctuation.
Growth & Income
The revenue growth year-over-year is 3.5%, while earnings growth is N/A due to the negative net income reported in the trailing twelve months. Since earnings are negative, they cannot grow faster than revenue in the traditional sense, and the lack of earnings growth data highlights the company's current phase of profitability challenges rather than a decline in sales momentum. Ascent Industries Co. does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all available cash flow and retained earnings back into its operations, research, or capital expenditures rather than distributing income to shareholders. This reinvestment strategy is consistent with a non-dividend payer profile where management prioritizes business expansion and operational restructuring over immediate shareholder returns. The overall growth and income profile presents a mixed picture characterized by steady revenue expansion but an absence of current profitability or dividend income, requiring investors to rely on potential future earnings improvements rather than current cash distributions.